SOPH SOPHiA GENETICS S.A. Gross Return on Sales

SOPHiA GENETICS SA (SOPH) generates revenue through subscriptions to cloud software for genomic analysis, as evidenced by the gross merchandise margin, where the current level is 66.40. The SaaS model ensures crisis resilience and low seasonality. Meanwhile, the platform's expansion across medical centers via ARR growth creates strong momentum, while long-term hospital contracts are already priced in.
Financial and market metric breakdowns for SOPHiA GENETICS S.A. (SOPH)

Growing demand for cloud-based genomic analysis in oncology is directly reflected in the gross margin, demonstrating the scaling efficiency of SOPHiA GENETICS services. This indicator is calculated as the ratio of the difference between revenue and cost of goods sold to total sales, allowing investors to assess the business's operational efficiency and its ability to generate profit before deducting administrative expenses.